Digital Twins in Healthcare Market - Global Forecast to 2030
商品番号 : SMB-36447
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
| ページ数 | 255 |
| 図表数 | 281 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、ヘルスケア市場におけるデジタルツインを分析しています。タイプ、コンポーネント、アプリケーション、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、この市場における主要プレーヤーの競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。
The global digital twin healthcare market is experiencing significant growth in 2024, driven by the growing applications of digital twins in healthcare and growing investments by public & private entities. The market is projected to reach USD 59.94 billion by 2030 from USD 4.47 billion in 2025, at a CAGR of 68.0% during the forecast period.
世界のデジタルツイン・ヘルスケア市場は、医療分野におけるデジタルツインの活用拡大と、官民両機関による投資の増加に牽引され、2024年には大幅な成長を遂げる見込みです。市場規模は、2025年の44億7,000万米ドルから2030年には599億4,000万米ドルに達し、予測期間中は年平均成長率（CAGR）68.0%で成長すると予測されています。
Public and private entities increasingly invest in digital twin technologies, recognizing their potential to drive innovation and enhance operational efficiency. Quibim, based in Valencia, is at the forefront of using imaging biomarkers for precision medicine. The company has recently completed a Series A funding round worth USD 50.6 million to establish a presence in the United States. Quibim views this as a significant step towards creating human digital twins—dynamic models that enable health monitoring and improve patient stratification, increase drug development success rates, and facilitate treatment testing before implementation.
官民両組織は、デジタルツイン技術がイノベーションを推進し、業務効率を向上させる可能性を認識し、投資を拡大しています。バレンシアに拠点を置くQuibimは、精密医療における画像バイオマーカーの活用において最前線に立っています。同社は最近、米国での事業展開を目指し、シリーズAの資金調達ラウンドで5,060万米ドルを調達しました。Quibimは、この資金調達を、人間のデジタルツインの構築に向けた重要な一歩と捉えています。デジタルツインとは、健康状態のモニタリング、患者の層別化の改善、医薬品開発の成功率の向上、そして治療導入前の試験の促進を可能にする動的モデルです。
“By application, the surgical planning & medical education segment accounted for the largest share of the market in 2024.”
In 2024, the surgical planning & medical education application segment accounted for the largest share of the market. The growth of this segment is due to the integration of digital twins with virtual reality platforms, which enhances surgical training for residents. This technology allows them to simulate procedures tailored to patients’ unique anatomical and physiological characteristics. As a result, trainees can experience a realistic representation of performance and track intraoperative metrics. Several companies have developed simulations of medical anatomy and surgical procedures to reduce the reliance on cadavers and promote interactive learning.
“By end user, the healthcare providers segment accounted for the largest share of the market in 2024.”
By end user, the healthcare providers segment accounted for the largest share of the market in 2024. The growth of this segment is attributed to its important role in workflow management and surgical planning. Digital twins offer additional benefits, such as accurate patient modeling, personalized treatment planning, and ongoing monitoring. These advantages contribute to enhanced clinical decision-making and improved patient outcomes.
“By region, Europe accounted for the second-largest market share in 2024.”
Europe accounted for the second-largest share of the market in 2024. Factors influencing advancements in healthcare include increased technological investments and the use of digital twins for research and genomics. According to the European Institute of Innovation & Technology (EIT) Health Germany, European nations are implementing digital twins to improve medication prescriptions. For example, the French company ExactCure, which specializes in digital health, is focused on preventing adverse drug effects. By utilizing cutting-edge omics, sensing, computing, and communication technologies, DigiTwins aims to enable completely personalized and preventive medicine, leading to a paradigm shift in healthcare.
The breakdown of primary participants is as mentioned below:
- By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
- By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Key Players in the Digital Twins in Healthcare Market
The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).
Research Coverage:
The report analyzes the Digital Twins in Healthcare Market. It aims to estimate the market size and future growth potential of various market segments based on type, component, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.
This report provides insights on:
Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market
- Product/Service Development & Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital twins in healthcare market
- Market Development: Comprehensive information on the lucrative emerging markets by type, component, application, end user, and region
- Market Diversification: Comprehensive information about product portfolios, expanding geographies, recent developments, and investments in the market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 MARKET SCOPE 26
1.3.1 MARKETS & REGIONS COVERED 26
1.3.2 INCLUSIONS & EXCLUSIONS 27
1.3.3 YEARS CONSIDERED 28
1.3.4 CURRENCY CONSIDERED 28
1.4 MARKET STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH APPROACH 29
2.1.1 SECONDARY RESEARCH 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Breakdown of primaries 32
2.1.2.3 Insights from primary experts 33
2.2 MARKET SIZE ESTIMATION 33
2.3 MARKET BREAKDOWN DATA TRIANGULATION 37
2.4 STUDY ASSUMPTIONS 38
2.5 RISK ASSESSMENT 38
2.6 RESEARCH LIMITATIONS 39
2.6.1 METHODOLOGY-RELATED LIMITATIONS 39
2.6.2 SCOPE-RELATED LIMITATIONS 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 45
4.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW 45
4.2 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT AND COUNTRY (2025) 46
4.3 DIGITAL TWINS IN HEALTHCARE MARKET: COUNTRY MIX 46
4.4 DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL MIX 47
4.5 DIGITAL TWINS IN HEALTHCARE MARKET:
DEVELOPED MARKETS VS. EMERGING ECONOMIES 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
5.2.1 MARKET DRIVERS 49
5.2.1.1 Increasing investments by public and private entities 49
5.2.1.2 Growing applications of digital twins 50
5.2.1.3 Technological advancements 50
5.2.1.4 Growing funding and investments in digital twin startups 51
5.2.2 RESTRAINTS 51
5.2.2.1 Managing data quality, privacy issues, and
high implementation costs 51
5.2.3 OPPORTUNITIES 52
5.2.3.1 Increasing focus on cutting-edge real-time data analytics 52
5.2.3.2 Growing importance of digital twins in emerging economies 52
5.2.4 CHALLENGES 53
5.2.4.1 Lack of skilled professionals 53
5.2.4.2 Integration with existing systems and outdated digital infrastructure 53
5.3 INDUSTRY TRENDS 53
5.3.1 TRANSFORMATION IN CLINICAL TRIALS 53
5.3.2 REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS 54
5.3.3 IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS 54
5.4 TECHNOLOGY ANALYSIS 54
5.4.1 TECHNOLOGY STACK 55
5.4.1.1 5G networks 55
5.4.1.2 Internet of Things 55
5.4.1.3 Cloud and edge computing 56
5.4.1.4 Blockchain 56
5.4.1.5 Augmented reality, virtual reality, and mixed reality 57
5.4.1.6 Artificial intelligence and machine learning 57
5.5 PORTER’S FIVE FORCES ANALYSIS 57
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 59
5.5.2 BARGAINING POWER OF SUPPLIERS 59
5.5.3 BARGAINING POWER OF BUYERS 59
5.5.4 THREAT OF NEW ENTRANTS 59
5.5.5 THREAT OF SUBSTITUTES 60
5.6 REGULATORY LANDSCAPE 60
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.7 VALUE CHAIN ANALYSIS 66
5.7.1 PLANNING & REVISING FUNDS 67
5.7.2 RESEARCH & DEVELOPMENT 67
5.7.3 SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT 67
5.7.4 PRODUCT/SOLUTION PROVIDERS 67
5.7.5 END USERS AND AFTER-SALES SERVICE PROVIDERS 67
5.8 ECOSYSTEM ANALYSIS 68
5.9 PATENT ANALYSIS 69
5.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 69
5.10 ADJACENT MARKET ANALYSIS 72
5.11 CASE STUDY ANALYSIS 73
5.11.1 UTILIZATION OF DIGITAL TWIN TECHNOLOGY FOR
SURGE PLANNING DECISIONS 73
5.11.2 PROVISION OF HOSPITAL GUIDANCE USING DIGITAL TWINS IN
HEALTHCARE DURING COVID-19 PANDEMIC 73
5.11.3 OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR
PERSONALIZED TREATMENTS 74
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 74
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
5.12.2 BUYING CRITERIA 75
5.13 KEY CONFERENCES & EVENTS, 2025−2026 76
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS 76
6 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT 77
6.1 INTRODUCTION 78
6.2 SERVICES 78
6.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO BOOST DEMAND 78
6.3 SOFTWARE 80
6.3.1 TRANSITION TO WEB/CLOUD-BASED MODELS TO PROPEL MARKET 80
7 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE 82
7.1 INTRODUCTION 83
7.2 PROCESS TWINS 83
7.2.1 RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO DRIVE MARKET 83
7.3 SYSTEM TWINS 84
7.3.1 INCREASING DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO FUEL MARKET 84
7.4 WHOLE BODY TWINS 86
7.4.1 TECHNOLOGICAL ADVANCEMENTS SUCH AS AI AND ML TO FUEL MARKET 86
7.5 BODY PART TWINS 87
7.5.1 GRADUAL PREFERENCE FOR PERSONALIZED & PRECISION
MEDICINE TO SUPPORT MARKET GROWTH 87
8 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION 89
8.1 INTRODUCTION 90
8.2 DRUG DISCOVERY & DEVELOPMENT 90
8.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY &
DEVELOPMENT TO BOOST MARKET 90
8.3 PERSONALIZED MEDICINE 92
8.3.1 COST-EFFECTIVE DEVELOPMENT & TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET GROWTH 92
8.4 SURGICAL PLANNING & MEDICAL EDUCATION 93
8.4.1 ABILITY ENHANCE TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST DEMAND 93
8.5 MEDICAL DEVICE DESIGN & TESTING 94
8.5.1 MINIMIZING RISKS AND REDUCING DOWNTIME TO DRIVE MARKET 94
8.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT 95
8.6.1 ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND
VALUABLE INSIGHTS TO SUPPORT DEMAND 95
8.7 OTHER APPLICATIONS 97
9 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER 99
9.1 INTRODUCTION 100
9.2 PHARMA & BIOPHARMA COMPANIES 100
9.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND
COST OF DRUG DEVELOPMENT TO BOOST ADOPTION 100
9.3 RESEARCH & ACADEMIA 102
9.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED
BY DIGITAL TWINS TO BOOST ADOPTION 102
9.4 HEALTHCARE PROVIDERS 103
9.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH 103
9.5 MEDICAL DEVICE COMPANIES 105
9.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION
OF MEDICAL DEVICES TO FUEL GROWTH 105
9.6 OTHER END USERS 106
10 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION 108
10.1 INTRODUCTION 109
10.2 NORTH AMERICA 109
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 110
10.2.2 US 113
10.2.2.1 Expanding applications of digital twins in healthcare to
bolster market growth 113
10.2.3 CANADA 115
10.2.3.1 Growing investments in digital twin development to drive market 115
10.3 EUROPE 117
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 118
10.3.2 GERMANY 120
10.3.2.1 Collaborations & partnerships to drive adoption of digital twins 120
10.3.3 UK 123
10.3.3.1 Growing applications of digital twins to support growth 123
10.3.4 FRANCE 125
10.3.4.1 Growing government funding for digital twin development to
bolster growth 125
10.3.5 ITALY 127
10.3.5.1 Rising focus on digital transformation for value-centric patient care to drive market 127
10.3.6 SPAIN 129
10.3.6.1 Rising funding investments for digital health plans to boost market 129
10.3.7 REST OF EUROPE 131
10.4 ASIA PACIFIC 134
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 135
10.4.2 JAPAN 138
10.4.2.1 Growing penetration of digital twin technologies to
support market growth 138
10.4.3 CHINA 140
10.4.3.1 China to register highest CAGR during forecast period 140
10.4.4 INDIA 142
10.4.4.1 Improvements in healthcare infrastructure to support market growth 142
10.4.5 REST OF ASIA PACIFIC 144
10.5 LATIN AMERICA 146
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 146
10.5.2 BRAZIL 149
10.5.2.1 Favorable digitization investments to support market growth 149
10.5.3 MEXICO 151
10.5.3.1 Supportive government strategies to fuel uptake 151
10.5.4 REST OF LATIN AMERICA 153
10.6 MIDDLE EAST & AFRICA 155
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 155
10.6.2 GCC COUNTRIES 157
10.6.2.1 Increasing healthcare infrastructure development and investments to support market growth 157
10.6.3 REST OF MIDDLE EAST AND AFRICA 159
11 COMPETITIVE LANDSCAPE 162
11.1 OVERVIEW 162
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET 162
11.3 REVENUE ANALYSIS, 2020−2024 164
11.4 MARKET SHARE ANALYSIS, 2024 165
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 167
11.5.1 STARS 167
11.5.2 EMERGING LEADERS 167
11.5.3 PERVASIVE PLAYERS 168
11.5.4 PARTICIPANTS 168
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 169
11.5.5.1 Region footprint 169
11.5.5.2 Company footprint 170
11.5.5.3 Component footprint 171
11.5.5.4 Application footprint 172
11.5.5.5 End-user footprint 173
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 174
11.6.1 PROGRESSIVE COMPANIES 174
11.6.2 RESPONSIVE COMPANIES 174
11.6.3 DYNAMIC COMPANIES 174
11.6.4 STARTING BLOCKS 174
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 176
11.6.5.1 Detailed list of key startups/SME players 176
11.6.5.2 Competitive benchmarking of key startups/SME players 177
11.7 COMPANY VALUATION & FINANCIAL METRICS 178
11.7.1 FINANCIAL METRICS 178
11.7.2 COMPANY VALUATION 178
11.8 BRAND/SOFTWARE COMPARISON 179
11.9 COMPETITIVE SCENARIO 180
11.9.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS 180
11.9.2 DEALS 181
11.9.3 EXPANSIONS 184
11.9.4 OTHER DEVELOPMENTS 184
12 COMPANY PROFILES 185
12.1 KEY PLAYERS 185
12.1.1 MICROSOFT CORPORATION 185
12.1.1.1 Business overview 185
12.1.1.2 Products/Services offered 186
12.1.1.3 Recent developments 187
12.1.1.3.1 Deals 187
12.1.1.4 MnM view 187
12.1.1.4.1 Key strengths 187
12.1.1.4.2 Strategic choices 187
12.1.1.4.3 Weaknesses & competitive threats 188
12.1.2 SIEMENS HEALTHINEERS AG 189
12.1.2.1 Business overview 189
12.1.2.2 Products/Services offered 190
12.1.2.3 Recent developments 191
12.1.2.3.1 Deals 191
12.1.2.4 MnM view 191
12.1.2.4.1 Key strengths 191
12.1.2.4.2 Strategic choices 192
12.1.2.4.3 Weaknesses & competitive threats 192
12.1.3 KONINKLIJKE PHILIPS N.V. 193
12.1.3.1 Business overview 193
12.1.3.2 Products/Services offered 194
12.1.3.3 Recent developments 195
12.1.3.3.1 Deals 195
12.1.3.4 MnM view 195
12.1.3.4.1 Key strengths 195
12.1.3.4.2 Strategic choices 195
12.1.3.4.3 Weaknesses & competitive threats 195
12.1.4 AMAZON WEB SERVICES, INC. 196
12.1.4.1 Business overview 196
12.1.4.2 Products/Services offered 197
12.1.4.3 Recent developments 198
12.1.4.3.1 Product/Service launches & enhancements 198
12.1.4.3.2 Deals 198
12.1.4.4 MnM view 198
12.1.4.4.1 Key strengths 198
12.1.4.4.2 Strategic choices 199
12.1.4.4.3 Weaknesses & competitive threats 199
12.1.5 DASSAULT SYSTÈMES 200
12.1.5.1 Business overview 200
12.1.5.2 Products/Services offered 201
12.1.5.3 Recent developments 202
12.1.5.3.1 Product/Service launches & enhancements 202
12.1.5.3.2 Deals 203
12.1.5.4 MnM view 204
12.1.5.4.1 Key strengths 204
12.1.5.4.2 Strategic choices 204
12.1.5.4.3 Weaknesses & competitive threats 204
12.1.6 GE HEALTHCARE 205
12.1.6.1 Business overview 205
12.1.6.2 Products/Services offered 206
12.1.6.3 Recent developments 207
12.1.6.3.1 Deals 207
12.1.7 ORACLE CORPORATION 208
12.1.7.1 Business overview 208
12.1.7.2 Products/Services offered 209
12.1.7.3 Recent developments 210
12.1.7.3.1 Product/Service enhancements 210
12.1.7.3.2 Deals 210
12.1.7.3.3 Expansions 211
12.1.8 IBM 212
12.1.8.1 Business overview 212
12.1.8.2 Products/Services offered 213
12.1.8.3 Recent developments 214
12.1.8.3.1 Deals 214
12.1.9 PTC 215
12.1.9.1 Business overview 215
12.1.9.2 Products/Services offered 216
12.1.9.3 Recent developments 217
12.1.9.3.1 Product/Service launches 217
12.1.9.3.2 Deals 217
12.1.10 SAP 218
12.1.10.1 Business overview 218
12.1.10.2 Products/Services offered 219
12.1.10.3 Recent developments 220
12.1.10.3.1 Deals 220
12.1.10.3.2 Other developments 220
12.1.11 ATOS SE 221
12.1.11.1 Business overview 221
12.1.11.2 Products/Services offered 222
12.1.11.3 Recent developments 222
12.1.11.3.1 Deals 222
12.1.12 NVIDIA CORPORATION 223
12.1.12.1 Business overview 223
12.1.12.2 Products/Services offered 224
12.1.12.3 Recent developments 225
12.1.12.3.1 Product/Service launches 225
12.1.12.3.2 Deals 226
12.1.13 ANSYS INC. 227
12.1.13.1 Business overview 227
12.1.13.2 Products/Services offered 228
12.1.13.3 Recent developments 229
12.1.13.3.1 Product/Service launches 229
12.1.13.3.2 Deals 229
12.1.14 FASTSTREAM TECHNOLOGIES 231
12.1.14.1 Business overview 231
12.1.14.2 Products/Services offered 231
12.1.15 RESCALE, INC. 232
12.1.15.1 Business overview 232
12.1.15.2 Products/Services offered 232
12.2 OTHER PAYERS 233
12.2.1 TWIN HEALTH 233
12.2.1.1 Business overview 233
12.2.1.2 Products/Services offered 233
12.2.1.3 Recent developments 233
12.2.1.3.1 Other developments 233
12.2.2 VERTO 234
12.2.2.1 Business overview 234
12.2.2.2 Products/Services offered 234
12.2.2.3 Recent developments 235
12.2.2.3.1 Deals 235
12.2.3 QBIO 236
12.2.3.1 Business overview 236
12.2.3.2 Products/Services offered 236
12.2.3.3 Recent developments 236
12.2.3.3.1 Product/Service launches 236
12.2.4 THOUGHTWIRE 237
12.2.4.1 Business overview 237
12.2.4.2 Products/Services offered 237
12.2.5 SIM AND CURE 238
12.2.5.1 Business overview 238
12.2.5.2 Products/Services offered 238
12.2.6 PREDICTIV 239
12.2.6.1 Business overview 239
12.2.6.2 Products/Services offered 239
12.2.7 NUREA 240
12.2.7.1 Business overview 240
12.2.7.2 Products/Services offered 240
12.2.7.3 Recent developments 240
12.2.7.3.1 Product/Service approvals 240
12.2.7.3.2 Deals 241
12.2.8 UNLEARN.AI, INC. 242
12.2.8.1 Business overview 242
12.2.8.2 Products/Services offered 242
12.2.8.3 Recent developments 243
12.2.8.3.1 Deals 243
12.2.8.3.2 Other developments 243
12.2.9 VIRTONOMY GMBH 244
12.2.9.1 Business overview 244
12.2.9.2 Products/Services offered 244
12.2.10 PREDISURGE 245
12.2.10.1 Business overview 245
12.2.10.2 Products/Services offered 245
12.2.10.3 Recent developments 246
12.2.10.3.1 Deals 246
12.2.10.3.2 Other developments 246
13 APPENDIX 247
13.1 DISCUSSION GUIDE 247
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 251
13.3 CUSTOMIZATION OPTIONS 253
13.4 RELATED REPORTS 253
13.5 AUTHOR DETAILS 254
LIST OF TABLES
TABLE 1 DIGITAL TWINS IN HEALTHCARE MARKET: INCLUSIONS & EXCLUSIONS 27
TABLE 2 DIGITAL TWINS IN HEALTHCARE MARKET: STUDY ASSUMPTIONS 38
TABLE 3 DIGITAL TWINS IN HEALTHCARE MARKET: RISK ASSESSMENT ANALYSIS 38
TABLE 4 MARKET DYNAMICS: DIGITAL TWINS IN HEALTHCARE MARKET 49
TABLE 5 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 60
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 61
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 62
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
TABLE 10 DIGITAL TWINS IN HEALTHCARE MARKET: REGULATORY STANDARDS 64
TABLE 11 KEY PATENTS IN DIGITAL TWINS IN HEALTHCARE MARKET 71
TABLE 12 CASE STUDY 1: UTILIZATION OF DIGITAL TWIN TECHNOLOGY
FOR SURGE PLANNING DECISIONS 73
TABLE 13 CASE STUDY 2: PROVISION OF HOSPITAL GUIDANCE USING
DIGITAL TWINS IN HEALTHCARE DURING COVID-19 PANDEMIC 73
TABLE 14 CASE STUDY 3: OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR PERSONALIZED TREATMENTS 74
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 75
TABLE 16 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS 75
TABLE 17 DIGITAL TWINS IN HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2025−2026 76
TABLE 18 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 78
TABLE 19 DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 79
TABLE 20 KEY SOFTWARE SOLUTIONS OFFERED BY MARKET PLAYERS 80
TABLE 21 DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 81
TABLE 22 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 83
TABLE 23 PROCESS TWINS CURRENTLY OFFERED BY MARKET PLAYERS 84
TABLE 24 PROCESS TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 84
TABLE 25 SYSTEM TWINS CURRENTLY OFFERED BY MARKET PLAYERS 85
TABLE 26 SYSTEM TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 85
TABLE 27 WHOLE BODY TWINS CURRENTLY OFFERED BY MARKET PLAYERS 86
TABLE 28 WHOLE BODY TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 87
TABLE 29 BODY PART TWINS CURRENTLY OFFERED BY MARKET PLAYERS 88
TABLE 30 BODY PART TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 88
TABLE 31 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 90
TABLE 32 DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 33 DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 34 DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING &
MEDICAL EDUCATION, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 35 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE
DESIGN & TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 36 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 37 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 38 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 100
TABLE 39 DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA &
BIOPHARMA COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 40 DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA,
BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 41 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 42 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 43 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 44 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 45 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 46 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 111
TABLE 47 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 111
TABLE 48 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 112
TABLE 49 NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER,
2023–2030 (USD MILLION) 112
TABLE 50 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 113
TABLE 51 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 114
TABLE 52 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 114
TABLE 53 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 115
TABLE 54 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 115
TABLE 55 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 116
TABLE 56 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 116
TABLE 57 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 117
TABLE 58 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 59 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 118
TABLE 60 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 119
TABLE 61 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 62 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 120
TABLE 63 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 121
TABLE 64 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 121
TABLE 65 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 122
TABLE 66 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 122
TABLE 67 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 123
TABLE 68 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 124
TABLE 69 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 124
TABLE 70 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 125
TABLE 71 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 126
TABLE 72 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 126
TABLE 73 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 126
TABLE 74 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 127
TABLE 75 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 127
TABLE 76 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 128
TABLE 77 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 128
TABLE 78 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 129
TABLE 79 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 129
TABLE 80 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 130
TABLE 81 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 130
TABLE 82 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 131
TABLE 83 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 132
TABLE 84 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 132
TABLE 85 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133
TABLE 86 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 133
TABLE 87 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 88 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 136
TABLE 89 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 136
TABLE 90 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 137
TABLE 91 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 137
TABLE 92 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 138
TABLE 93 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 138
TABLE 94 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 139
TABLE 95 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 139
TABLE 96 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 140
TABLE 97 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 140
TABLE 98 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 141
TABLE 99 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 141
TABLE 100 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 142
TABLE 101 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 143
TABLE 102 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 143
TABLE 103 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 144
TABLE 104 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 144
TABLE 105 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 145
TABLE 106 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145
TABLE 107 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION) 146
TABLE 108 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 109 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 147
TABLE 110 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 147
TABLE 111 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148
TABLE 112 LATIN AMERICA: DIGITAL TWINS IN MARKET, BY END USER,
2023–2030 (USD MILLION) 148
TABLE 113 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 149
TABLE 114 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 115 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 150
TABLE 116 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 117 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2023–2030 (USD MILLION) 151
TABLE 118 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 151
TABLE 119 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 152
TABLE 120 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 121 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 153
TABLE 122 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 123 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 154
TABLE 124 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY END USER, 2023–2030 (USD MILLION) 154
TABLE 125 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 126 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY COMPONENT, 2023–2030 (USD MILLION) 156
TABLE 127 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 128 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 156
TABLE 129 MIDDLE EAST & AFRICA: DIGITAL TWINS IN MARKET, BY END USER,
2023–2030 (USD MILLION) 157
TABLE 130 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 158
TABLE 131 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 132 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 158
TABLE 133 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2023–2030 (USD MILLION) 159
TABLE 134 REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 159
TABLE 135 REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 136 REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160
TABLE 137 REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION) 161
TABLE 138 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
DIGITAL TWINS IN HEALTHCARE MARKET, JANUARY 2021–MARCH 2025 162
TABLE 139 DIGITAL TWINS IN HEALTHCARE MARKET: DEGREE OF COMPETITION 165
TABLE 140 DIGITAL TWINS IN HEALTHCARE MARKET: REGION FOOTPRINT 169
TABLE 141 DIGITAL TWINS IN HEALTHCARE MARKET: COMPONENT FOOTPRINT 171
TABLE 142 DIGITAL TWINS IN HEALTHCARE MARKET: APPLICATION FOOTPRINT 172
TABLE 143 DIGITAL TWINS IN HEALTHCARE MARKET: END-USER FOOTPRINT 173
TABLE 144 DIGITAL TWINS IN HEALTHCARE MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2021–MARCH 2025 180
TABLE 145 DIGITAL TWINS IN HEALTHCARE MARKET: DEALS, JANUARY 2021–JANUARY 2025 181
TABLE 146 DIGITAL TWINS IN HEALTHCARE MARKET:
EXPANSIONS, JANUARY 2021–MARCH 2025 184
TABLE 147 DIGITAL TWINS IN HEALTHCARE MARKET:
OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 184
TABLE 148 MICROSOFT CORPORATION: COMPANY OVERVIEW 185
TABLE 149 MICROSOFT CORPORATION: PRODUCTS/SERVICES OFFERED 186
TABLE 150 MICROSOFT CORPORATION: DEALS, JANUARY 2021–MARCH 2025 187
TABLE 151 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 189
TABLE 152 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 190
TABLE 153 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–MARCH 2025 191
TABLE 154 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 193
TABLE 155 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 194
TABLE 156 KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2021–MARCH 2025 195
TABLE 157 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 196
TABLE 158 AMAZON WEB SERVICES, INC.: PRODUCTS/SERVICES OFFERED 197
TABLE 159 AMAZON WEB SERVICES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–MARCH 2025 198
TABLE 160 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021–MARCH 2025 198
TABLE 161 DASSAULT SYSTÈMES: COMPANY OVERVIEW 200
TABLE 162 DASSAULT SYSTÈMES: PRODUCTS/SERVICES OFFERED 201
TABLE 163 DASSAULT SYSTÈMES: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–MARCH 2025 202
TABLE 164 DASSAULT SYSTÈMES: DEALS, JANUARY 2021–MARCH 2025 203
TABLE 165 GE HEALTHCARE: COMPANY OVERVIEW 205
TABLE 166 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 206
TABLE 167 GE HEALTHCARE: DEALS, JANUARY 2021–MARCH 2025 207
TABLE 168 ORACLE CORPORATION: COMPANY OVERVIEW 208
TABLE 169 ORACLE CORPORATION: PRODUCTS/SERVICES OFFERED 209
TABLE 170 ORACLE CORPORATION: PRODUCT/SERVICE ENHANCEMENTS,
JANUARY 2021–MARCH 2025 210
TABLE 171 ORACLE CORPORATION: DEALS, JANUARY 2021–MARCH 2025 210
TABLE 172 ORACLE CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2025 211
TABLE 173 IBM: COMPANY OVERVIEW 212
TABLE 174 IBM: PRODUCTS/SERVICES OFFERED 213
TABLE 175 IBM: DEALS, JANUARY 2021–MARCH 2025 214
TABLE 176 PTC: COMPANY OVERVIEW 215
TABLE 177 PTC: PRODUCTS/SERVICES OFFERED 216
TABLE 178 PTC: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025 217
TABLE 179 PTC: DEALS, JANUARY 2021–MARCH 2025 217
TABLE 180 SAP: COMPANY OVERVIEW 218
TABLE 181 SAP: PRODUCTS/SERVICES OFFERED 219
TABLE 182 SAP: DEALS, JANUARY 2021–MARCH 2025 220
TABLE 183 SAP: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 220
TABLE 184 ATOS SE: COMPANY OVERVIEW 221
TABLE 185 ATOS SE: PRODUCTS/SERVICES OFFERED 222
TABLE 186 ATOS SE: DEALS, JANUARY 2021–MARCH 2025 222
TABLE 187 NVIDIA CORPORATION: COMPANY OVERVIEW 223
TABLE 188 NVIDIA CORPORATION: PRODUCTS/SERVICES OFFERED 224
TABLE 189 NVIDIA CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–MARCH 2025 225
TABLE 190 NVIDIA CORPORATION: DEALS, JANUARY 2021–MARCH 2025 226
TABLE 191 ANSYS INC.: COMPANY OVERVIEW 227
TABLE 192 ANSYS INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025 229
TABLE 193 ANSYS INC.: DEALS, JANUARY 2021–MARCH 2025 229
TABLE 194 FASTSTREAM TECHNOLOGIES: COMPANY OVERVIEW 231
TABLE 195 FASTSTREAM TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 231
TABLE 196 RESCALE, INC.: COMPANY OVERVIEW 232
TABLE 197 RESCALE, INC.: PRODUCTS/SERVICES OFFERED 232
TABLE 198 TWIN HEALTH: COMPANY OVERVIEW 233
TABLE 199 TWIN HEALTH: PRODUCTS/SERVICES OFFERED 233
TABLE 200 TWIN HEALTH: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 233
TABLE 201 VERTO: COMPANY OVERVIEW 234
TABLE 202 VERTO PRODUCTS/SERVICES OFFERED 234
TABLE 203 VERTO: DEALS, JANUARY 2021–MARCH 2025 235
TABLE 204 QBIO: COMPANY OVERVIEW 236
TABLE 205 QBIO: PRODUCTS/SERVICES OFFERED 236
TABLE 206 QBIO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025 236
TABLE 207 THOUGHTWIRE: COMPANY OVERVIEW 237
TABLE 208 THOUGHTWIRE: PRODUCTS/SERVICES OFFERED 237
TABLE 209 SIM AND CURE: COMPANY OVERVIEW 238
TABLE 210 SIM AND CURE: PRODUCTS/SERVICES OFFERED 238
TABLE 211 PREDICTIV: COMPANY OVERVIEW 239
TABLE 212 PREDICTIV: PRODUCTS/SERVICES OFFERED 239
TABLE 213 NUREA: COMPANY OVERVIEW 240
TABLE 214 NUREA: PRODUCTS/SERVICES OFFERED 240
TABLE 215 NUREA: PRODUCT/SERVICE APPROVALS, JANUARY 2021–MARCH 2025 240
TABLE 216 NUREA: DEALS, JANUARY 2021–MARCH 2025 241
TABLE 217 UNLEARN.AI, INC.: COMPANY OVERVIEW 242
TABLE 218 UNLEARN.AI, INC.: PRODUCTS/SERVICES OFFERED 242
TABLE 219 UNLEARN.AI, INC.: DEALS, JANUARY 2021–MARCH 2025 243
TABLE 220 UNLEARN.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 243
TABLE 221 VIRTONOMY GMBH: BUSINESS OVERVIEW 244
TABLE 222 VIRTONOMY GMBH: PRODUCTS/SERVICES OFFERED 244
TABLE 223 PREDISURGE: COMPANY OVERVIEW 245
TABLE 224 PREDISURGE: PRODUCTS/SERVICES OFFERED 245
TABLE 225 PREDISURGE: DEALS, JANUARY 2021–MARCH 2025 246
TABLE 226 PREDISURGE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 246
LIST OF FIGURES
FIGURE 1 DIGITAL TWINS IN HEALTHCARE MARKET:
SEGMENTATION & GEOGRAPHIC SPREAD 26
FIGURE 2 DIGITAL TWINS IN HEALTHCARE MARKET: YEARS CONSIDERED 28
FIGURE 3 RESEARCH DESIGN 29
FIGURE 4 PRIMARY SOURCES 31
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 32
FIGURE 6 BOTTOM-UP APPROACH 34
FIGURE 7 TOP-DOWN APPROACH 34
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF DIGITAL TWINS IN HEALTHCARE INDUSTRY 35
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
FIGURE 10 DIGITAL TWINS IN HEALTHCARE MARKET: DATA TRIANGULATION 37
FIGURE 11 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2025 VS. 2030 (USD MILLION) 40
FIGURE 12 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 41
FIGURE 13 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 42
FIGURE 14 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 43
FIGURE 15 GEOGRAPHIC SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET 44
FIGURE 16 INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF
PATIENT-CENTRIC HEALTHCARE TO PROPEL MARKET 45
FIGURE 17 SOFTWARE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2025 46
FIGURE 18 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 46
FIGURE 19 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 47
FIGURE 21 DIGITAL TWINS IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 48
FIGURE 22 DIGITAL TWIN TECHNOLOGIES 55
FIGURE 23 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 24 VALUE CHAIN ANALYSIS 66
FIGURE 25 DIGITAL TWINS IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 68
FIGURE 26 GLOBAL PATENT PUBLICATION TRENDS IN DIGITAL TWINS IN HEALTHCARE MARKET, 2017–2024 69
FIGURE 27 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR DIGITAL TWIN PATENTS (JANUARY 2017–DECEMBER 2024) 70
FIGURE 28 TOP APPLICANTS FOR DIGITAL TWIN PATENTS (COUNTRY/REGION) (JANUARY 2017–DECEMBER 2024) 70
FIGURE 29 METAVERSE IN HEALTHCARE MARKET: MARKET OVERVIEW 72
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 74
FIGURE 31 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS 75
FIGURE 32 DIGITAL TWINS IN HEALTHCARE MARKET: TRENDS/DISRUPTIONS
IMPACTING BUYERS 76
FIGURE 33 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 110
FIGURE 34 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 135
FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN
HEALTHCARE MARKET, 2020–2024 (USD MILLION) 164
FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN
HEALTHCARE MARKET (2024) 165
FIGURE 37 DIGITAL TWINS IN HEALTHCARE MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 168
FIGURE 38 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY FOOTPRINT 170
FIGURE 39 DIGITAL TWINS IN HEALTHCARE MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 175
FIGURE 40 EV/EBITDA OF KEY VENDORS 178
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND
5-YEAR STOCK BETA OF KEY VENDORS 178
FIGURE 42 DIGITAL TWINS IN HEALTHCARE MARKET: BRAND/SOFTWARE COMPARISON 179
FIGURE 43 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2024) 186
FIGURE 44 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 190
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 194
FIGURE 46 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2024) 197
FIGURE 47 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2024) 201
FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 206
FIGURE 49 ORACLE CORPORATION: COMPANY SNAPSHOT (2024) 209
FIGURE 50 IBM: COMPANY SNAPSHOT (2024) 213
FIGURE 51 PTC: COMPANY SNAPSHOT (2024) 216
FIGURE 52 SAP: COMPANY SNAPSHOT (2024) 219
FIGURE 53 ATOS SE: COMPANY SNAPSHOT (2024) 221
FIGURE 54 NVIDIA CORPORATION: COMPANY SNAPSHOT (2024) 224
FIGURE 55 ANSYS INC.: COMPANY SNAPSHOT (2023) 228
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 中空糸型限外ろ過市場 – 2030年までの世界予測 2025-05-07
- 車載カメラ市場 – 2032年までの世界予測 2025-05-07
- 自動車内装市場 – 2032年までの世界予測 2025-05-06
- 穿孔治具市場 – 2030年までの世界予測 2025-05-06
- 耐火潤滑剤市場 – 2030年までの世界予測 2025-05-05